Oncology
Iberdomide Combination Approved for Relapsed Myeloma
The accelerated approval covers eligible adults with previously treated multiple myeloma after exposure to both a proteasome inhibitor and an immunomodulatory agent.
Rayan Salih · August 31, 2026 · 6 min